Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNF superfamily member 13 | 0.499 | 0.769 | 0.82 |
|
disease | 0.500 | None | 1.000 | 15 | 1 | 2011 | 2020 | ||||||||
|
vav guanine nucleotide exchange factor 3 | 0.603 | 0.615 | 8.5E-14 |
|
disease | 0.410 | None | 1.000 | 2 | 1 | 2014 | 2017 | ||||||||
|
caspase recruitment domain family member 9 | 0.566 | 0.654 | 8.1E-13 |
|
disease | 0.410 | None | 1.000 | 2 | 1 | 2014 | 2017 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.894 | 47 | 3 | 1995 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.400 | None | 0.833 | 24 | 2 | 1993 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.400 | None | 0.957 | 23 | 1 | 1995 | 2020 | ||||||||
|
complement factor H related 3 | 0.663 | 0.462 | 1.7E-11 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2011 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 1991 | 2016 | ||||||||
|
complement factor H related 1 | 0.588 | 0.615 | 2.6E-08 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2011 | 2017 | ||||||||
|
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | 0.780 | 0.308 | 7.5E-15 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2007 | 2009 | ||||||||
|
sprouty RTK signaling antagonist 2 | 0.554 | 0.654 | 0.97 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2012 | 2015 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
secretoglobin family 1A member 1 | 0.546 | 0.808 | 8.0E-04 |
|
disease | 0.300 | None | 0.929 | 14 | 0 | 1997 | 2007 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.300 | None | 1.000 | 12 | 0 | 2001 | 2018 | ||||||||
|
defensin alpha 5 | 0.695 | 0.423 | 5.2E-06 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
complement C1q A chain | 0.623 | 0.654 | 3.8E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 1996 | 2014 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
G protein-coupled receptor 183 | 0.700 | 0.462 | 1.7E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
complement C1q B chain | 0.711 | 0.538 | 0.15 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
aurora kinase B | 0.510 | 0.769 | 4.5E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
leukocyte associated immunoglobulin like receptor 1 | 0.569 | 0.692 | 3.3E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
membrane spanning 4-domains A6A | 0.821 | 0.231 | 8.4E-13 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
solute carrier family 43 member 3 | 0.861 | 0.154 | 2.2E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 |